EE05200B1 - Asitromtsiin monohdraadina, selle valmistamismeetod ja selle kasutamine ravimkoostises - Google Patents

Asitromtsiin monohdraadina, selle valmistamismeetod ja selle kasutamine ravimkoostises

Info

Publication number
EE05200B1
EE05200B1 EEP200300255A EEP200300255A EE05200B1 EE 05200 B1 EE05200 B1 EE 05200B1 EE P200300255 A EEP200300255 A EE P200300255A EE P200300255 A EEP200300255 A EE P200300255A EE 05200 B1 EE05200 B1 EE 05200B1
Authority
EE
Estonia
Prior art keywords
monoh
azithromycin
drape
preparation
pharmaceutical compositions
Prior art date
Application number
EEP200300255A
Other languages
English (en)
Estonian (et)
Inventor
Centellas Victor
Diago Jos�
Garcia Rafael
Ludescher Johannes
Original Assignee
Biochemie S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0031355A external-priority patent/GB0031355D0/en
Application filed by Biochemie S.A. filed Critical Biochemie S.A.
Publication of EE200300255A publication Critical patent/EE200300255A/xx
Publication of EE05200B1 publication Critical patent/EE05200B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
EEP200300255A 2000-11-27 2001-11-26 Asitromtsiin monohdraadina, selle valmistamismeetod ja selle kasutamine ravimkoostises EE05200B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25311900P 2000-11-27 2000-11-27
GB0031355A GB0031355D0 (en) 2000-12-21 2000-12-21 Organic compounds
PCT/EP2001/013760 WO2002042315A2 (en) 2000-11-27 2001-11-26 Macrolide solvates

Publications (2)

Publication Number Publication Date
EE200300255A EE200300255A (et) 2003-08-15
EE05200B1 true EE05200B1 (et) 2009-08-17

Family

ID=26245472

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300255A EE05200B1 (et) 2000-11-27 2001-11-26 Asitromtsiin monohdraadina, selle valmistamismeetod ja selle kasutamine ravimkoostises

Country Status (15)

Country Link
US (1) US6949519B2 (xx)
EP (1) EP1339730A2 (xx)
JP (1) JP2004519430A (xx)
KR (1) KR100815163B1 (xx)
AU (1) AU2002221895A1 (xx)
BG (1) BG66200B1 (xx)
CA (1) CA2429639C (xx)
CZ (1) CZ303343B6 (xx)
EE (1) EE05200B1 (xx)
HR (1) HRP20030430B1 (xx)
HU (1) HU229488B1 (xx)
NO (1) NO324951B1 (xx)
PL (1) PL207076B1 (xx)
SK (1) SK287814B6 (xx)
WO (1) WO2002042315A2 (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
NZ529118A (en) 2001-05-22 2005-10-28 Pfizer Prod Inc Crystal forms of azithromycin
GB0214277D0 (en) * 2002-06-20 2002-07-31 Biochemie Gmbh Organic compounds
US6855813B2 (en) 2002-07-19 2005-02-15 Alembic Limited Process for the preparation of azithromycin monohydrate
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
GB0224197D0 (en) * 2002-10-17 2002-11-27 Biochemie Gmbh Organic compounds
US20040266997A1 (en) * 2003-03-25 2004-12-30 Michael Pesachovich Degradation products of azithromycin, and methods for their indentification
US20050101547A1 (en) * 2003-11-06 2005-05-12 Sadatrezaei Mohsen Stabilized azithromycin composition
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
US7384921B2 (en) 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US7683162B2 (en) * 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
JP4471941B2 (ja) * 2005-03-10 2010-06-02 山一電機株式会社 半導体装置用ソケット
US20090318375A1 (en) * 2005-06-08 2009-12-24 Hanmi Pharm Co., Ltd Crystalline Azithromycin L-Malate Monohydrate and Pharmaceutical Composition Containing Same
BRPI1009823A2 (pt) 2009-03-13 2019-09-24 Da Volterra Assistance Publique Hopitaux De Paris E Univ Paris Diderot Paris 7 "composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit."

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
UA27040C2 (uk) 1987-07-09 2000-02-28 Пфайзер Інк. Кристалічhий дигідрат азитроміциhу та спосіб одержаhhя кристалічhого дигідрату азитроміциhу
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
PT102006B (pt) * 1997-05-19 2000-06-30 Hovione Sociedade Quimica S A Novo processo de preparacao de azitromicina
PT102130A (pt) * 1998-03-13 1999-09-30 Hovione Sociedade Quimica S A Processo de preparacao de dihidrato de azitromicina
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
CN1273142C (zh) * 1998-11-30 2006-09-06 特瓦制药工业有限公司 阿齐霉素的乙醇化物,制备方法以及医药组合物
AU5820400A (en) * 1999-06-29 2001-01-31 Biochemie S.A. Macrolides
ES2177373B1 (es) * 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina

Also Published As

Publication number Publication date
BG66200B1 (bg) 2012-01-31
JP2004519430A (ja) 2004-07-02
WO2002042315A3 (en) 2002-10-31
SK6352003A3 (en) 2003-11-04
PL361276A1 (en) 2004-10-04
KR100815163B1 (ko) 2008-03-19
CA2429639A1 (en) 2002-05-30
HUP0302099A3 (en) 2009-08-28
CZ303343B6 (cs) 2012-08-08
PL207076B1 (pl) 2010-10-29
HUP0302099A2 (hu) 2003-10-28
CZ20031439A3 (cs) 2003-10-15
WO2002042315A2 (en) 2002-05-30
CA2429639C (en) 2009-07-14
HRP20030430A2 (en) 2005-04-30
EE200300255A (et) 2003-08-15
NO324951B1 (no) 2008-01-14
SK287814B6 (sk) 2011-11-04
AU2002221895A1 (en) 2002-06-03
HRP20030430B1 (en) 2011-11-30
HU229488B1 (hu) 2014-01-28
KR20030055305A (ko) 2003-07-02
US6949519B2 (en) 2005-09-27
BG107832A (bg) 2004-07-30
US20040053862A1 (en) 2004-03-18
NO20032371D0 (no) 2003-05-26
EP1339730A2 (en) 2003-09-03
NO20032371L (no) 2003-07-10

Similar Documents

Publication Publication Date Title
EE05200B1 (et) Asitromtsiin monohdraadina, selle valmistamismeetod ja selle kasutamine ravimkoostises
EE04567B1 (et) Kristalliline monohdraat, meetod selle valmistamiseks ja selle kasutamine ravimi valmistamiseks
EE200300207A (et) Heterotsüklüülalküülpiperidiini derivaadid, nendevalmistamismeetodid ja farmatseutiline kompositsioon
EE200300587A (et) Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine
EE200300145A (et) Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon
EE200300237A (et) Difenüülasetidinooni derivaadid, nende kasutamine, ravim ja selle valmistamismeetod
EE200300238A (et) Difenüülasetidinooni derivaadid, nende kasutamine, ravim ja selle valmistamismeetod
EE200400028A (et) Ravimpreparaat, selle valmistamise meetod ja selle kasutamine meditsiinis
EE05157B1 (et) N-[(asendatud bensüül)-4-piperidinüüli v?i pürrolidinüül]aminohüdroksüalkoksüfenüülide derivaadid, meetod nende valmistamiseks ning nende kasutamine meditsiinis
EE200100684A (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200200484A (et) Väikeseannuseline entekaviiripreparaat ja selle kasutamine
DE60045394D1 (de) Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen
HUP0302114A3 (en) Liquis pharmaceutical composition comprising erythropoietin protein, method for its preparation and its use
EE05081B1 (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, 3-aminoasetidiini derivaadid ja nende valmistamise meetodid
MA27049A1 (fr) Derives de 1-phenylsulfonyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique
EE200100568A (et) 6-alkenüül-, 6-alkünüül- ja 6-epoksüepotilooni derivaadid, nende valmistamismeetod ja kasutamine farmatseutilistes preparaatides
EE200300048A (et) Bensimidasooli derivaadid, nende valmistamine ja terapeutiline kasutamine
EE200000596A (et) Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja kasutamine ning vaheühend ja selle valmistamismeetod
EE05242B1 (et) 5-kloro-3-(4-metaansulfonlfenl)-6'-metl[2,3']bipridinli polmorfne vorm, selle valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
AP2003002744A0 (en) Heparin-derived polysaccharide mixtures preparation method and pharmaceutical compositions containing same
FI20011671A0 (fi) Tuumorispesifiset oligosakkaridisekvenssit ja niiden käyttö
EE04717B1 (et) Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
FI20000818A0 (fi) Dermatologinen käyttö ja valmiste
EE05175B1 (et) Asendatud bensimidasooli preparaat, meetod selle valmistamiseks ja selle kasutamine meditsiinis
BR0208566B1 (pt) Derivados de Beta-Carbolina, Seu Uso, e composição Farmacêutica

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20151126